BioMed Research International / 2012 / Article / Tab 1 / Research Article
Topical Application Effect of the Isolectin Hydrogel (Cramoll 1,4) on Second-Degree Burns: Experimental Model Table 1 Effect of topical administration of hydrogel containing 100 μ g per mL isolectin Cramoll 1,4 on the hematological parameters of Wistar rats. Assays performed in triplicate for each parameter. G1 = Treatment, G2 = control. Mean ± SD (
𝑛
=
2
).
Parameters 7th day 14th day 21st day 28th day 35th day G1 G2 G1 G2 G1 G2 G1 G2 G1 G2 Erythrogram Erythrocytes mil/mm3
6
.
7
±
0
.
0
1
7
.
2
±
0
.
1
4
7
.
1
±
0
.
1
6
7
.
5
7
±
0
.
6
9
7
.
6
±
0
.
6
9
7
.
5
±
0
.
4
2
6
.
3
2
±
0
.
5
6
8
.
1
±
0
.
2
1
6
.
3
±
0
.
7
1
7
.
7
±
0
.
9
2
Hemoglobin g/dL
1
3
.
9
±
0
.
0
1
1
3
±
0
.
1
4
1
4
.
8
±
0
.
5
2
1
5
.
5
9
±
0
.
4
1
1
5
.
6
±
0
.
4
1
1
2
.
4
±
0
.
6
4
1
3
.
7
±
0
.
3
8
1
2
.
8
±
0
.
4
9
1
4
.
1
±
0
.
3
2
1
4
.
5
±
0
.
4
2
Hematocrit %
3
8
.
7
±
0
.
2
2
4
1
.
1
±
0
.
4
9
4
0
.
6
±
0
.
5
6
4
3
.
2
2
±
0
.
9
6
4
3
.
2
±
0
.
9
6
4
1
±
0
.
8
5
3
8
.
5
±
0
.
5
5
3
9
.
8
±
0
.
9
2
4
1
.
9
±
0
.
8
4
4
0
.
8
±
0
.
4
9
Platelet count Platelets mil/mm3
8
4
4
0
0
0
±
0
.
7
1
8
0
5
0
0
0
±
0
.
7
1
6
5
6
0
0
0
±
0
.
7
1
9
2
6
0
0
0
±
0
7
1
7
8
8
0
0
0
±
0
.
7
1
8
2
0
0
0
0
±
0
.
7
1
8
4
4
0
0
0
±
0
.
7
1
7
8
9
0
0
0
±
0
.
7
1
7
4
9
0
0
0
±
0
.
7
1
8
9
2
0
0
0
±
0
.
7
1
WBC Leukocytes %
7
2
0
0
±
0
.
7
1
8
0
0
0
±
0
.
7
1
8
1
0
0
±
0
.
7
1
7
9
0
0
±
0
.
7
1
1
2
0
0
0
±
0
.
7
1
8
1
0
0
±
0
.
7
1
9
3
0
0
±
0
.
7
1
7
9
0
0
±
0
.
7
1
8
0
0
0
±
0
.
7
1
8
0
0
0
±
0
.
7
1
Neutrophils %
1
5
.
1
±
0
.
0
7
2
6
.
8
±
0
.
7
8
2
6
.
4
±
0
.
2
8
3
1
.
3
±
0
.
5
6
8
.
7
±
0
.
6
3
2
8
.
8
±
0
.
4
2
1
4
.
7
±
0
.
7
1
2
7
.
5
±
0
.
7
1
1
6
.
1
±
0
.
2
3
3
.
1
±
0
.
9
9
Eosinophils %
0
±
0
0
.
1
±
0
.
1
4
0
.
1
±
0
.
0
7
1
.
6
±
0
.
2
8
0
.
1
±
0
.
0
7
2
.
4
±
0
.
2
8
0
.
1
±
0
.
1
4
1
.
3
±
0
.
1
4
0
.
1
±
0
1
.
5
±
0
.
0
7
Basophils %
0
.
2
±
0
0
.
2
±
0
.
1
4
0
.
2
±
0
.
0
7
0
.
2
±
0
0
.
2
±
0
0
.
2
±
0
.
1
4
0
.
2
±
0
0
.
2
±
0
0
0
.
2
±
0
0
.
1
±
0
typical lymphocytes %
8
1
.
4
±
0
.
6
4
8
1
.
5
±
0
.
4
9
6
8
.
5
±
0
.
7
0
8
6
.
8
5
±
0
.
7
8
8
7
.
1
±
0
.
8
4
8
2
.
7
±
0
.
4
9
8
1
.
5
±
0
.
5
6
7
9
.
9
±
0
.
7
1
8
3
.
7
±
0
.
4
6
8
0
.
9
±
0
.
7
8
atypical lymphocytes %
0
±
0
0
±
0
0
0
±
0
0
0
±
0
0
0
±
0
0
±
0
0
±
0
0
±
0
0
0
±
0
0
±
0
Monocytes %
1
.
4
±
0
.
0
7
2
±
0
.
7
1
1
.
2
±
0
.
0
7
2
±
0
0
1
.
2
±
0
.
0
7
1
.
5
±
0
.
7
1
1
.
4
±
0
.
0
7
1
.
5
±
0
.
7
1
1
.
2
±
0
.
0
7
2
.
5
±
0
.
7
1
